Fundraising Archives

ori biotech cell therapy manufacturing cells

News and Trends 18 Jan 2022

Ori Biotech Bags €88M Investment to Automate Cell Therapy Manufacture

The UK company Ori Biotech has raised €88M ($100M) in Series B cash to ease the cell therapy manufacturing bottleneck using automation and standardized data collection. The round was 40% oversubscribed and led by the US investment firm Novalis LifeSciences. The Chinese investor Puhua Capital and Chimera Abu Dhabi joined the existing syndicate, which includes […]

January 18, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 14 Jan 2022

Europe Trailed US Despite Record Gene and Cell Therapy Funding in 2021

Cell and gene therapy developers globally raised an all-time annual record in 2021. However, European firms missed out on the funding growth. Companies around the world developing cell and gene therapies raised €20.1B ($23.1B) over 2021, said the advanced therapy advocacy organization the Alliance for Regenerative Medicine (ARM) in a briefing this week. This bumper […]

January 14, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 5 Jan 2022

The Top European Biotech Investments in December

December 2021 ended with a bang for biotech funding in Europe and Israel, with cultured meat and cell therapy startups attracting the biggest investment rounds. Biotech companies in Europe and Israel capped off 2021 with a very strong month of fundraising. Collectively, private companies and those launching initial public offerings (IPOs) banked almost €1.6B in […]

January 5, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 23 Dec 2021

Future Meat Lands €308M in Biggest-Ever Cultured Meat Investment

The Israeli firm Future Meat Technologies has raised a neat €308M ($347M) in the biggest financing round in the field of cultured meat to date. The company claims rapid progress in addressing scaling bottlenecks that slow the sector’s growth. A range of contributors pitched into the mammoth funding round including an undisclosed tech investor, ADM […]

December 23, 2021 - 5 minutesmins - By Jonathan Smith

Best in Biotech 22 Dec 2021

The Biggest European Biotech News of 2021

In spite of the challenges posed by the Covid-19 pandemic, the European biotech industry has emerged stronger than ever this year. These were the key moments for the sector in 2021. The year 2021 has seen skyrocketing fortunes for many European biotech players. Investment firms, for instance, raised far more funding than in 2020, which […]

December 22, 2021 - 10 minutesmins - By Jonathan Smith

News and Trends 10 Dec 2021

European Biotech Investors Cap Off Record Year in Fundraising

The year 2021 is closing with a biotech investment rush as Eir Ventures, Apollo Health Ventures, and Merck’s venture capital arm M Ventures raise impressive funds to speed up life sciences innovation. This year is set to break records in terms of the money flowing into institutional life science investors. With 2021 not even finished, […]

December 10, 2021 - 4 minutesmins - By Jonathan Smith

News and Trends 8 Dec 2021

The Top European Biotech Investment Rounds in November

A €375M IPO from Evotec was the highlight of European biotech investments in November, with other cash going to firms working on cell therapy reprogramming and immuno-oncology. The total biotech investment haul for European companies reached €1.2B in November, with 41 deals in the bag. These deals included European and Israeli companies launching a private […]

December 8, 2021 - 4 minutesmins - By Jonathan Smith

News and Trends 10 Nov 2021

Evotec IPO Hints At Stabilizing Investor Interest In Biotech Stocks

German life sciences heavyweight Evotec raised around €376M ($435M) in its US debut on the Nasdaq last week, fueling tentative hopes of renewed investor interest in biotech stocks after a rollercoaster year. The company downsized its initial IPO target of around €500M ($576M) by offering fewer shares than initially planned. This is widely seen as […]

November 10, 2021 - 4 minutesmins - By Victor Kotsev

News and Trends 2 Nov 2021

The Top European Biotech Investment Rounds in October

DNA manufacturing was a hot topic in biotech investments in October, with immuno-oncology and insect protein also drawing big investor excitement. After the huge biotech investment rounds that took place in September, October was a quieter month for private European and Israeli life sciences firms. Collectively, they raised €555.6M in 37 deals. This was less […]

November 2, 2021 - 5 minutesmins - By Jonathan Smith

News and Trends 28 Oct 2021

DNA Manufacturing Startups Net Venture Capital Windfalls

Touchlight Genetics and DNA Script have closed major venture financing rounds in the last month as investor excitement mounts over the next generations of DNA manufacturing. DNA Script made a big splash in Paris this week as it raked in €142M in Series C funding. The company will ramp up the commercialization of its benchtop […]

October 28, 2021 - 6 minutesmins - By Jonathan Smith

News and Trends 19 Oct 2021

Biotech VCs Face Funding Bulge Amid Struggling Stock Markets

Despite volatile biotech stocks limiting options for exit, Sofinnova Partners’ latest €472M fund highlights ballooning European venture capital and its growing focus on early-stage biotech investments. Biotech fundraising broke records in 2020 as the Covid-19 pandemic swept the globe. This year seems set to continue biotech’s winning streak in private fundraising. One example is a […]

October 19, 2021 - 5 minutesmins - By Jonathan Smith

oxford nanopore technologies genomics sequencing

News and Trends 15 Oct 2021

Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO

Oxford Nanopore Technologies, until recently one of very few unicorns in the European biotech industry, had a stellar IPO on the London Stock Exchange late last month. This is ushering in a whole new generation of DNA sequencing, genetics research, and diagnostics. During the first day of the IPO, which bagged the firm over €400M […]

October 15, 2021 - 5 minutesmins - By Victor Kotsev

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us